|
Mdrs 2517506-2021-00031, 2517506-2021-00032, 2517506-2021-00033, 2517506-2021-00034, 2517506-2021-00035, 2517506-2021-00036, 2517506-2021-00037, 2517506-2021-00038, and 2517506-2021-00039 were filed for the same event.The customer contacted siemens customer care center (ccc) and reported a discordant, falsely elevated cardiac troponin i (ctni) patient result was obtained on a dimension vista 1500 system.Siemens is investigating the event.
|
|
Mdrs 2517506-2021-00031 supplement 1, 2517506-2021-00032 supplement 1, 2517506-2021-00033 supplement 1, 2517506-2021-00034 supplement 1, 2517506-2021-00035 supplement 1, 2517506-2021-00036 supplement 1, 2517506-2021-00037 supplement 1, 2517506-2021-00038 supplement 1, and 2517506-2021-00039 supplement 1 were filed for the same event.Additional information (01-apr-2021): siemens healthcare diagnostics headquarters support center (hsc) concluded their investigation of the falsely elevated cardiac troponin i (ctni) results on multiple dates for one specific patient.Hsc reviewed the information provided by the customer.Hsc communicated to the customer that there is a possibility that the patient in question possessed a heterophilic antibody.Hsc requested the customer send the patient sample to siemens for further investigation.Since the event reported occurred in 2018, no patient sample from the event was available for evaluation.The dimension vista cardiac troponin i (ctni) flex reagent cartridge instructions for use states: "patient samples may contain heterophilic antibodies that could react in immunoassays to give falsely elevated or depressed results.This assay has been designed to minimize interference from heterophilic antibodies.Nevertheless, complete elimination of this interference from all patient specimens cannot be guaranteed.A test result that is inconsistent with the clinical picture and patient history should be interpreted with caution." the customer has accepted the conclusion of the siemens investigation as a possible explanation for the cause of the event.No potential product problem with the assay or instrument has not been identified.The cause of the event is unknown.The device is performing within specifications.No further evaluation is required.Section h6 has been updated to reflect the hsc investigation.Initial mdr was filed 26-jan-2021.Mdrs 2517506-2021-00031, 2517506-2021-00032, 2517506-2021-00033, 2517506-2021-00034, 2517506-2021-00035, 2517506-2021-00036, 2517506-2021-00037, 2517506-2021-00038, and 2517506-2021-00039 were filed for the same event.
|